in Aerospace

Dnata awarded UK MHRA certification for Good Distribution Practice

Posted 19 April 2018 · Add Comment

Global air services provider and UK ground handler, dnata, has been awarded certification for Good Distribution Practice (GDP) by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA).


Courtesy dnata

The UK MHRA granted dnata full Wholesaler Dealer Authorisation (WDA) after dnata completed the organisation’s Good Distribution Programme, while simultaneously investing into cutting-edge pharma handling technology at several of its facilities.

Dnata’s investment includes a sophisticated 24-hour warehouse monitoring system that has the ability to conduct temperature mapping and advise dnata operators ahead of any deviation in temperature. This, in, turn enables pre-planning, quick response to adapt to adverse weather conditions and assessment of potential transport routes for pharma products.

Temperature mapping is also routinely conducted within dnata’s facilities in the summer and winter to gauge average temperatures.

This leading-edge technology recently paid dividends when the cold front struck in early March and temperatures across the UK plummeted. dnata was able to prepare for the severe temperature onslaught, and ensure that all pharmaceuticals handled followed the optimum route, at temperatures that limited the risk of spoilage.

In addition, the company has installed automated handling systems that can store pharmaceuticals at variable temperature ranges.

In order to achieve certification, dnata was required to either review or make enhancements to its quality systems, operations documentation and facilities management practices – a 12 to 24-month process that it completed in just six months.

“We have invested in pharma-handling facilities across the UK in response to customer demand and in recognition of the growing importance of pharma cold-chain logistics,” said dnata UK CEO Gary Morgan.

“With world-class technology already in place at our facilities, the next logical step was to ensure standards compliance and achieve UK MHRA certification.  These initiatives not only demonstrate our ongoing focus on safety and quality, but also reinforce our commitment to our airline customers who operate in the fast-growing pharmaceutical transportation sector.”

* required field

Post a comment

Other Stories
Advertisement
Latest News

Air Partner appointed by airBaltic to remarket three B737-500s

Air Partner Remarketing has been appointed by airBaltic as its exclusive remarketing agent for three B737-500s.

Manchester Airport marks one year of £1bn transformation

Manchester Airport is marking one year of construction on the biggest investment project in its history by releasing images showing the work completed so far.

Stansted launches NAP consultation

London Stansted has launched a public consultation on its draft Noise Action Plan (NAP) setting out the airport’s approach to managing aircraft noise and reducing its impact on the local community.

Dstl scientists' sepsis test now available for commercial licence

A new test for sepsis, which globally claims six million lives a year, could soon be available thanks to an innovation by scientists at the Defence Science and Technology Laboratory (Dstl).

Culdrose Merlins join HMS Queen Elizabeth to support F-35 deck landings

Aircraft, aircrew and support personnel from 820 Naval Air Squadron (NAS) have embarked HMS Queen Elizabeth to support her forthcoming F-35B flight trials.

First ACJ320neo is assembled

The first ACJ320neo has been assembled on programme, fitted with CFM International LEAP-1A engines and painted in ACJ house-colours, in preparation for a first flight in the coming weeks.

ODU SK191217191218
See us at
DVD18BT3105200918AdvancedEngin BT1406011118SMIFAVSBT151118SMI GMSCBT3005081118Aviation Africa 2019